Edition:
United Kingdom

Biotechnology & Medical Research

Akebia Therapeutics Says Anticipates Delayed Filing Of Annual Report On Form 10-K

March 18 (Reuters) - Akebia Therapeutics Inc ::AKEBIA THERAPEUTICS ANNOUNCES PRELIMINARY FULL-YEAR 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS.AKEBIA THERAPEUTICS INC - ENDED 2018 WITH CASH, CASH EQUIVALENTS AND AVAILABLE-FOR-SALE SECURITIES OF $321.6 MILLION.AKEBIA - SEES CASH RESOURCES,...

8:05pm GMT

Evolus Reports Q4 Loss Per Share $0.46

March 18 (Reuters) - Evolus Inc ::EVOLUS REPORTS FOURTH QUARTER AND FULL YEAR 2018 RESULTS.Q4 LOSS PER SHARE $0.46.Q4 EARNINGS PER SHARE ESTIMATE $-0.55 -- REFINITIV IBES DATA.

8:04pm GMT

Cohbar Q4 Loss Per Share $0.10

CohBar Inc ::COHBAR REPORTS FOURTH QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q4 LOSS PER SHARE $0.10.HAD CASH AND INVESTMENTS OF $22,182,768 ON DECEMBER 31, 2018.

8:03pm GMT

AquaBounty Technologies Announces Proposed Public Offering Of Common Stock

March 18 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.

8:00pm GMT

Expansion & New Markets

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.